We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
AUM
$324M
AUM Growth
+$13.5M
Cap. Flow
+$78.7K
Cap. Flow %
0.02%
Top 10 Hldgs %
30.79%
Holding
71
New
2
Increased
26
Reduced
36
Closed
2

Top Buys

Rank Stock Value
1
RHI icon
Robert Half
RHI
+$778K
2
DLX icon
Deluxe
DLX
+$560K
3
ORLY icon
O'Reilly Automotive
ORLY
+$456K
4
HBI
Hanesbrands
HBI
+$379K
5
KDP icon
Keurig Dr Pepper
KDP
+$348K

Top Sells

Rank Stock Value
1
SYK icon
Stryker
SYK
+$557K
2
TPR icon
Tapestry
TPR
+$517K
3
XOM icon
ExxonMobil
XOM
+$483K
4
BKE icon
Buckle
BKE
+$421K
5
AME icon
Ametek
AME
+$411K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.78%
2 Technology 17.78%
3 Industrials 15.68%
4 Healthcare 15.36%
5 Consumer Staples 13.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPN icon
26
Global Payments
GPN
$21.9B
$5.64M 1.74%
87,394
+142
+0.2% +$9.58K
NVO
27
Novo Nordisk
NVO
$222B
$5.61M 1.73%
193,120
+5,590
+3% +$155K
VAR
28
DELISTED
Varian Medical Systems, Inc.
VAR
$5.58M 1.72%
78,770
-327
-0.4% -$22.6K
SLGN icon
29
Silgan Holdings
SLGN
$4.91B
$5.57M 1.72%
207,386
-900
-0.4% -$23.8K
PKG icon
30
Packaging Corp of America
PKG
$20.4B
$4.85M 1.5%
76,901
+3,944
+5% +$260K
PII icon
31
Polaris
PII
$4.12B
$4.76M 1.47%
55,412
+2,276
+4% +$241K
K
32
DELISTED
Kellanova
K
$4.65M 1.44%
68,489
-282
-0.4% -$18.4K
DLX icon
33
Deluxe
DLX
$1.18B
$4.64M 1.43%
85,101
+9,707
+13% +$560K
EV
34
DELISTED
Eaton Vance Corp.
EV
$4.62M 1.43%
142,333
-2,462
-2% -$86.3K
SYK icon
35
Stryker
SYK
$123B
$4.19M 1.29%
45,055
-5,825
-11% -$557K
ABBV icon
36
AbbVie
ABBV
$450B
$4.07M 1.26%
68,668
-142
-0.2% -$8.18K
COL
37
DELISTED
Rockwell Collins
COL
$3.82M 1.18%
41,404
-231
-0.6% -$20.5K
ORLY icon
38
O'Reilly Automotive
ORLY
$70.4B
$3.73M 1.15%
220,740
+26,310
+14% +$456K
CNI icon
39
Canadian National Railway
CNI
$77.8B
$3.64M 1.13%
65,176
+2,861
+5% +$167K
VSTO
40
DELISTED
Vista Outdoor Inc.
VSTO
$3.59M 1.11%
80,674
-2,472
-3% -$108K
OA
41
DELISTED
Orbital ATK, Inc.
OA
$3.4M 1.05%
38,124
-4,174
-10% -$351K
DHR icon
42
Danaher
DHR
$143B
$3.16M 0.98%
50,695
-855
-2% -$53.5K
PDCO
43
DELISTED
Patterson Companies, Inc.
PDCO
$2.98M 0.92%
65,906
-758
-1% -$34.9K
KMB icon
44
Kimberly-Clark
KMB
$36B
$2.96M 0.91%
23,236
-30
-0.1% -$3.6K
HBI
45
DELISTED
Hanesbrands
HBI
$2.63M 0.81%
89,240
+12,645
+17% +$379K
LH icon
46
Labcorp
LH
$23.1B
$2.62M 0.81%
24,631
-82
-0.3% -$8.46K
LLY icon
47
Eli Lilly
LLY
$1.05T
$2.61M 0.81%
31,030
-392
-1% -$32.5K
CLB icon
48
Core Laboratories
CLB
$514M
$2.01M 0.62%
18,480
-2,920
-14% -$334K
MDT icon
49
Medtronic
MDT
$107B
$1.84M 0.57%
23,877
-770
-3% -$58K
EXPD icon
50
Expeditors International
EXPD
$23.6B
$1.74M 0.54%
38,690
-42
-0.1% -$2.04K

Similar funds

JLB & Associates's Q4 2015 Portfolio in Review

As of Q4 2015, JLB & Associates held 71 positions worth $324M, up 4.4% from $310M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

JLB & Associates's Q4 2015 filing shows 2 new, 26 increased, 36 reduced and 2 closed positions. Its largest new stake was Robert Half: 15,429 shares worth $727K. The largest sale was Stryker, an estimated $557K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.

  • JLB & Associates's largest Q4 2015 buy was Robert Half: 15,429 shares worth $727K.
  • JLB & Associates added most to Deluxe in Q4 2015, an estimated $560K increase.
  • JLB & Associates's biggest Q4 2015 reduction was Stryker, cutting an estimated $557K.
  • JLB & Associates fully exited Buckle in Q4 2015, selling an estimated $421K.
  • JLB & Associates's ten largest holdings make up 31% of its $324M portfolio in Q4 2015.
  • JLB & Associates opened 2 new positions and closed 2 in Q4 2015.
  • JLB & Associates's portfolio value rose 4.4% quarter-over-quarter to $324M.

Based on JLB & Associates's 13F filing for Q4 2015, filed 1 Feb 2016.